메뉴 건너뛰기




Volumn 6, Issue 4, 2006, Pages 373-381

Anti-interleukin-6 receptor antibody therapy in rheumatic diseases

Author keywords

Crohn' s disease activity index (CDAI); Cytokines; Multicentric Castleman's disease (MCD); Rheumatoid arthritis (RA); Tocilizumab

Indexed keywords

ADALIMUMAB; ATLIZUMAB; CORTICOSTEROID; CYTOKINE; DISEASE MODIFYING ANTIRHEUMATIC DRUG; ETANERCEPT; IMMUNOSUPPRESSIVE AGENT; INFLIXIMAB; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 6; INTERLEUKIN 6 ANTIBODY; INTERLEUKIN 6 RECEPTOR; ISONIAZID; METHOTREXATE; PLACEBO; RITUXIMAB; TUMOR NECROSIS FACTOR ALPHA ANTIBODY; VASCULOTROPIN;

EID: 33845655897     PISSN: 18715303     EISSN: None     Source Type: Journal    
DOI: 10.2174/187153006779025694     Document Type: Review
Times cited : (38)

References (50)
  • 7
    • 0024360388 scopus 로고
    • Kishimoto, T. (1989) Blood, 74(1), 1-10.
    • (1989) Blood , vol.74 , Issue.1 , pp. 1-10
    • Kishimoto, T.1
  • 26
    • 0036845130 scopus 로고    scopus 로고
    • the European Group of Clinical Investigators
    • Nuki, G.; Bresnihan, B.; Bear, M.B.; McCabe, D.; the European Group of Clinical Investigators. (2002) Arthritis Rheum., 46(11), 2838-2846.
    • (2002) Arthritis Rheum. , vol.46 , Issue.11 , pp. 2838-2846
    • Nuki, G.1    Bresnihan, B.2    Bear, M.B.3    McCabe, D.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.